Press Releases from Prudent Markets (11323 total)
Australian Huntington Disease Therapeutics Market Size and Share 2023 | Upcoming …
Report Overview
The Australian Huntington Disease (HD) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Huntington disease (HD) is an inherited condition characterized by the progressive degeneration of neurons within certain areas of the brain (e.g., basal ganglia, cerebral cortex). People with HD usually live for about 15 to 20…
Australian Batten's Disease (CLN-2) Therapeutics Market Evolution Segmentation a …
The Australian Batten's Disease (CLN-2) Therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Batten disease (Jansky-Bielschowsky disease) is the common name for a family of severe and progressive neurological disorders (also known as neuronal ceroid lipofuscinoses - NCLs) that primarily affect children. Collectively, Batten disease is the most common…
Australian X-linked Myotubular Myopathy (XLMTM) Therapeutics Market Size, Share, …
Report Overview
The Australian X-linked Myotubular Myopathy (XLMTM) Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
X-linked myotubular myopathy (XLMTM) is a rare genetic neuromuscular disorder that is characterized by muscle weakness that is most typically severe but can range from mild to profound. Symptoms are often present at birth,…
Recent News Stories Shows How The Australian Sarcoglycanopathies Therapeutics Ma …
Report Overview
The Australian Sarcoglycanopathies Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Limb-girdle muscular dystrophies (LGMD) are a group of rare progressive genetic disorders that are characterized by wasting (atrophy) and weakness of the voluntary muscles of the hip and shoulder areas (limb-girdle area). These forms of LGMD may…
Comprehensive Analysis On Australian MPS VI Therapeutics Market 2023 With Future …
Report Overview
The Australian MPS VI Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
MPS VI is an inherited disorder that encompasses a wide spectrum of severity. Physical symptoms may include bone and joint malformation, hearing and vision problems, and heart and breathing difficulties. The rate of disease progression and…
Australian Sanfillipo Syndrome (MPS III) Therapeutics Market Expected to Grow Fa …
Report Overview
The Australian Sanfillipo Syndrome Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Mucopolysaccaridosis III (MPS III) is a rare genetic condition that causes fatal brain damage. It is also known as Sanfilippo syndrome and is a type of childhood dementia. MPS III is caused by a lack of…
Australian Hunter Syndrome Therapeutics Market Insights and In-Depth Analysis 20 …
Report Overview
The Australian Hunter Syndrome Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
MPS II is an inherited disorder that encompasses a wide spectrum of severity. In some people the brain may be affected in combination with physical symptoms; others may develop physical symptoms with no brain involvement. Hunter…
Australian Fabry Disease Therapeutics Market 2023 Is Booming Worldwide | Latest …
Report Overview
The Australian Fabry Disease Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Fabry Disease (also known as Anderson-Fabry Disease) is a rare genetic disorder which is caused by the deficiency of defective gene i.e., alpha-galactosidase-A gene (GLA gene) which leads to deficiency of an alpha-galactosidase enzyme. Alpha-galactosidase A…
Australian Hereditary Angioedema Therapeutics Market 2023 | Estimate CAGR Analys …
Report Overview
The Australian Hereditary Angioedema Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Hereditary Angioedema is a rare inherited disorder characterized by recurrent episodes of the accumulation of fluids outside of the blood vessels, blocking the normal flow of blood or lymphatic fluid and causing rapid swelling of tissues…
Australian Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market Si …
Report Overview
The Australian Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Neuromyelitis Optica Spectrum Disorder (NMOSD) is previously known as Devic Syndrome, a rare and devastating, autoimmune, inflammatory disorder of the central nervous system (CNS) characterized by severe axonal damage, primarily to the optic…
Australian Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics Market Evolu …
Report Overview
The Australian FOP therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which muscle tissue and connective tissue such as tendons and ligaments are replaced by bone, forming bone outside the skeleton (extra-skeletal or heterotopic bone) which restricts the…
Australian Guillain-Barre Syndrome (GBS)Therapeutics Market Size, Share, Price, …
Report Overview
The Australian Guillain-Barre Syndrome Therapeutics Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Guillain-Barre Syndrome is a rare condition concerning the immune system of the body. In Guillain-Barre Syndrome, the bodys immune system starts attacking the bodys own nervous system, resulting in pain and loss of sensation, as well…
Recent News Stories Shows How The Australian Myasthenia Gravis Market Products A …
Report Overview
The Australian Myasthenia Gravis Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
It is an autoimmune condition which causes problems with the transmission of signals from the nerves to the muscles. Myasthenia Gravis affects the muscles that control eye movement, facial expression, chewing, and swallowing in its early stages.…
Comprehensive Analysis On Australian Cystic Fibrosis Therapeutics Market 2023 Wi …
Report Overview
The Australian Cystic Fibrosis Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Cystic Fibrosis is a hereditary disorder, which majorly affects lungs and other body parts such as pancreas, liver, and kidney. It is caused by the mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This gene…
Australian Dental Care Services Market Expected to Grow Faster According to New …
Report Overview
The Australian dental care services market size stood at around USD 10.0 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The rise in awareness amongst people regarding cosmetic dental treatment aids in improving aesthetics and maintaining the fresh breath, which is also one of the key factors positively impacting the demand for oral care products. The…
Australian Pharmacy Market 2023 To Show Startling Growth During Forecast Period …
Report Overview
The Australian Pharmacies market size stood at USD 39.5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Long-term economic, demographic, and social trends are forecast to support the Pharmacies industry over the next forecasted years. The industry will also likely benefit from Australia's aging population and increasing health consciousness. However, ongoing PBS reforms and the loss…
Australian Home Healthcare Market Insights and In-Depth Analysis 2023-2028 with …
Report Overview
The Australian Home Healthcare market size was valued at USD xx billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
Rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices. In 2017, there were 3.8 million…
Latest Report Of Australian Cardiovascular Disease Market Growth, Opportunities, …
Report Overview
The Australian Cardiovascular disease market size stood at around USD 10.4 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The rise in the prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing cardiac deaths and favorable reimbursement initiatives. Cardiovascular hospitalization rates were 30% higher among those living in remote and very remote areas than…
Japan Multiple Sclerosis Drugs Market Growing Trade Among Emerging Economies Ope …
Report Overview
The Japan Multiple Sclerosis Drugs Market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Extensive research and development activity in multiple sclerosis treatment, increasing prevalence of multiple sclerosis and growing need for better multiple sclerosis treatment options are the major drivers which will propel the demand for MS drugs in the…
Japan Telemedicine Market Report with Executive Summary, Size, Analysis and Fore …
Report Overview
The Japan telemedicine market size stood at around USD 220 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Modern ICTs are revolutionizing how individuals communicate with each other, seek and exchange information, and enriching their lives. These technologies have great potential to help address modern health issues. These recent advancements in, and increasing availability and utilization…
Japan Dermatological Therapeutics Market 2023 : Projected to Deliver Greater Rev …
Report Overview
The Japan dermatological market size stood at around USD 6.7 million in 2020 and is projected to reach USD XX million by 2028, exhibiting a CAGR of xx% during the forecast period.
With the rise in the ageing population in Japan, dermatological care is likely to receive particular attention. As people age, the risk of developing skin-related disorders increases, due to factors, such as changes in the connective tissue, reduction…
According to Latest Report on United Kingdom Inflammatory Bowel Disease Market 2 …
Report Overview
The UK Inflammatory Bowel Disease drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 4.7% during the forecast period.
IBD is one of the key chronic inflammatory digestive disease prevalent in the country. The disease is caused by several factors including the changing lifestyle of the population, prevalence of Crohn's disease in the country are…
Impact of COVID-19 Outbreak on United Kingdom Anti-depressants Market to Witness …
Report Overview
The UK Antidepressants market size stood at around USD xx billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.
Depression mainly occurs due to the factors, such as social isolation and stressful work environment, which contributed the most to increasing the number of people suffering from depression. The number of people falling prey to depression and related…
United Kingdom Osteoporosis Drugs Market 2023 Is Ready to Set Outstanding Growth …
Report Overview
The UK Osteoporosis Drugs Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Osteoporosis is defined as a medical condition, which is characterized by low density and quality of bones in humans. Furthermore, the bones become porous in this medical condition, which makes them more fragile and, in turn, prone…
United Kingdom Primary Hyperoxaluria (PH) Therapeutics Market Growing Trade Amon …
Report Overview
The UK Primary Hyperoxaluria Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Primary Hyperoxaluria (PH) is an ultra-orphan disease caused by genetic mutations, which results in the build-up of overproduction and accumulation of oxalate in the body. This results in the deposition of calcium oxalate crystals in the…
United Kingdom Rett Syndrome Therapeutics Market Business Scenario Analysis By G …
Report Overview
The UK Rett Syndrome Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Rett syndrome is a rare genetic neurological disorder that is more common among girls and leads to severe impairment affecting their ability to speak, walk and eat. Rett syndrome is recognized in children between 6-18 months…
United Kingdom Alport Syndrome Therapeutics Market Size, Competitive Landscape, …
Report Overview
The UK Alport Syndrome Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Alport syndrome is a rare genetic disorder caused by the gene mutation of COL4A3, COL4A4, or COL4A5 & characterized by progressive kidney disease and abnormalities of the inner ear and the eye. Two major types of…
Latest Report Of United Kingdom Wilson Disease Therapeutics Market Growth, Oppor …
Report Overview
The UK Wilson Disease Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Wilson disease (WD), also known as hepatolenticular degeneration, and progressive lenticular degeneration, is a rare genetic disorder of copper metabolism characterized by excess copper stored in various body tissues, particularly the liver, brain, and corneas…
United Kingdom Frontotemporal Dementia (FTD) Therapeutics Market Growing Trade A …
Report Overview
The UK Frontotemporal Dementia therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Frontotemporal dementia (FTD) is the name given to dementia when it is due to progressive damage to the frontal and/or temporal lobes of the brain. The right and left frontal lobes at the front of the…
United Kingdom Friedreich Ataxia Therapeutics Market Report with Executive Summa …
Report Overview
The UK Friedreich Ataxia (FRDA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Friedreichs ataxia (FRDA) is the most common inherited ataxia in the UK. FRDA is a genetic, progressive, neurodegenerative movement disorder, that primarily affects the nervous system and the heart with a typical age of onset…
United Kingdom Angelman Syndrome Therapeutics Market 2023 : Projected to Deliver …
Report Overview
The UK Angelman Syndrome Therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Angelman syndrome (AS) is a rare genetic and neurological disorder characterized by severe developmental delay and learning disabilities; absence or near absence of speech; inability to coordinate voluntary movements (ataxia); tremulousness with jerky movements of…
According to Latest Report on United Kingdom X-linked Myotubular Myopathy (XLMTM …
Report Overview
The UK X-Linked Myotubular Myopathy (XLMTM) therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The X-linked myotubular myopathy (XLMTM) is the most common form of centronuclear myopathy (CNM). The XLMTM is a rare genetic neuromuscular disorder that is characterized by muscle weakness that is most typically severe but…
Impact of COVID-19 Outbreak on United Kingdom Duchenne Muscular Dystrophy Therap …
Report Overview
The UK Duchenne Muscular Dystrophy Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Duchenne Muscular Dystrophy, or DMD, is a debilitating genetic condition that causes a gradual loss of muscle function that affects everyday movements and activities. Muscular dystrophy is a condition that causes progressive wasting of the…
United Kingdom Morquio Syndrome (MPS IV) Therapeutics Market 2023 Is Ready to Se …
Report Overview
The UK Morquio Syndrome Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Morquio Syndrome (MPS IV) is an ultra-rare autosomal recessive inherited disorder and a member of a group of hereditary metabolic diseases known as the mucopolysaccharidoses (MPS) which, in turn, are part of a larger group of…
United Kingdom Mucopolysaccharidosis I Therapeutics Market Growing Trade Among E …
Report Overview
The UK Mucopolysaccharidosis I Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Mucopolysaccharidosis I (MPS I) is a member of a group of hereditary metabolic diseases known as the mucopolysaccharidoses which, in turn, are part of a larger group of diseases known as lysosomal storage disorders (LSDs). Mutations…
United Kingdom Pompe Disease Therapeutics Market Business Scenario Analysis By G …
Report Overview
The UK Pompe Disease Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Pompe Disease also known as Type II glycogen storage disease (GSDII), is a rare autosomal recessively inherited metabolic disorder caused by the accumulation of glycogen takes place in the lysosome that affects people of all ages.…
United Kingdom Gaucher Disease Therapeutics Market Size, Competitive Landscape, …
Report Overview
The UK Gaucher Disease Therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Gaucher disease is a rare, inherited metabolic disorder in which deficiency of the enzyme glucocerebrosidase results in the accumulation of harmful quantities of certain fats (lipids), specifically the glycolipid glucocerebroside, throughout the body especially within the…
Latest Report Of United Kingdom Lysosomal Storage Disorders Therapeutics Market …
Report Overview
The UK Lysosomal Storage Disorders Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
LSDs usually is caused by a deficiency of a single lysosomal enzyme or protein, which results in a build-up of lipid or sugar in the lysosome. There are many lysosomal enzymes and they each work…
United Kingdom Autoimmune Haemolytic Anaemia Therapeutics Market Growing Trade A …
Report Overview
The UK Autoimmune Haemolytic Anaemia (AIHA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
AIHA is an autoimmune disorder characterised by the premature destruction of healthy red blood cells (RBCs) by auto-antibodies. It is a common disorder directed against self RBCs which can be idiopathic (primary) or secondary.…
United Kingdom Paroxysmal Nocturnal Haemoglobinuria Therapeutics Market Report w …
Report Overview
The UK Paroxysmal Nocturnal Haemoglobinuria Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Paroxysmal Nocturnal Haemoglobinuria (PNH) is a very rare and debilitating disease of the bone marrow that affects the blood and major organs. It is a chronic, life-threatening illness and can have devastating effects upon a…
United Kingdom Hypophosphatasia Therapeutics Market 2023 : Projected to Deliver …
Report Overview
The UK Hypophosphatasia (HPP) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Hypophosphatasia (HPP) is also known as Rathbun disease is an ultra-rare metabolic genetic disorder characterized by the abnormal development of bones and teeth due to defective mineralization, a process by which bones and teeth use minerals…
According to Latest Report on United Kingdom Chronic Inflammatory Demyelinating …
Report Overview
The UK Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Chronic Inflammatory Demyelinating Polyneuritis (CIDP) is a rare autoimmune disorder wherein the body's immune system attacks the myelin causing various symptoms such as numbness, weakness, and a lack of certain reflexes.
CIDP is a…
Impact of COVID-19 Outbreak on United Kingdom Interstitial Cystitis Therapeutics …
Report Overview
The UK Interstitial Cystitis (IC) Therapeutics market size stood at around USD 0.075 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
According to the Interstitial Cystitis Association (ICA), Interstitial cystitis (IC), is a bladder condition that usually consists of multiple symptoms. Interstitial Cystitis also called Painful Bladder Syndrome, is a chronic condition causing bladder pressure, bladder…
United Kingdom Transthyretin Amyloidosis Therapeutics Market 2023 Is Ready to Se …
Report Overview
The UK Transthyretin Amyloidosis (ATTR) Therapeutics market size stood at around USD 0.012 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Transthyretin Amyloidosis (ATTR) is caused by the transthyretin (TTR) protein and occurs in two forms, either hereditary or wild type. Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure in older individuals.…
United Kingdom Healthcare Diagnostic Market Growing Trade Among Emerging Economi …
Report Overview
The UK Healthcare Diagnostic market is expected to grow from USD xx million in 2019 to USD xx million by 2028, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from (2019-2028).
Diagnostics market in the UK is in its growth phase due to increase in incidence of chronic diseases such as arthritis, cancer, cardiovascular diseases, neurodegenerative disorder, and diabetes. According to WHO, 75% of the…
United Kingdom Home Healthcare Market Business Scenario Analysis By Global Indus …
Report Overview
The U.K home healthcare market size was valued atUSD 1,196 Millionin 2019 and is growing exhibiting a CAGR of xx% in the forecast period (2019-2028).
A rapid aging population with more than 65 years of age prone to chronic illness such as diabetes,hypertensions, Alizheimers mental illness, intinence, e.t.c. are likely to bosst the demand for easy to access and cost effective home healthcare systems. According to provisional figure published by…
United Kingdom CAR T cell Therapy Market Size, Competitive Landscape, Regional O …
Report Overview
UK CAR T cell Therapy Market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of xx% during the forecast period (2019-2028).
UK is leading the CAR T cell therapy market of this region due to growing research and development activities. Government Initiatives taken for introducing reimbursement policies in support of the poor people are leveling up the…
Latest Report Of United Kingdom Prostate Cancer Diagnostic and Therapeutic Marke …
Report Overview
UKs Prostate Cancer market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 9.7% during the forecast period.
The high incidence of prostate cancer is the major factor for augmenting the demand for prostate cancer diagnostics services and therapeutics in UK. As per the World Health Organization, around 56,000 new cases of prostate cancer were…
United Kingdom Melanoma Market Growing Trade Among Emerging Economies Opening Ne …
Report Overview
UKs Melanoma market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around xx% during the forecast period.
Although melanoma is still more common in adults older than 65 years, the rates for patients aged 25 to 49 years have increased by 70% since the 1990s, according to the press release. The awareness of melanoma is…
United Kingdom Leukaemia Therapeutics Market Report with Executive Summary, Size …
Report Overview
UKs Leukaemia Therapeutics market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX.X% during the forecast period.
Leukaemia is the 12th most common cancer in the UK, accounting for 3% of all new cancer cases. In females in the UK, leukaemia is the 12th most common cancer, with around 4,000 new cases. In males…